期刊文献+

老年人下肢动脉病变预后随访及危险因素分析 被引量:2

Analysis of prognosis and risk factors in the elderly patients with 1ower extremity atherosclerotic disease
原文传递
导出
摘要 目的:分析老年人下肢动脉病变发生的影响因素及其预后的影响。方法:回顾性分析2004~2009年于哈尔滨医科大学第一临床医学院干部二病房明确诊断为下肢动脉病变的住院患者181例。全部行双下肢动脉彩色多普勒检查,按照动脉病变程度将患者分为3组:斑块组、狭窄组(≥50%)和闭塞组。收集其性别、年龄、血脂、空腹血糖(FBG)、纤维蛋白原(FIB)、高血压、脑卒中及吸烟史等信息。比较不同病变组一般情况及生化指标间的差异,并对老年下肢动脉粥样硬化病变危险因素采用回归方法进行分析。所有患者均接受16个月随访,观察患者的主要终点事件包括下肢坏疽、侧支循环、死亡。结果:①年龄、糖尿病病程、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL-C)、FBG、血脂异常、性别比例、糖尿病、冠心病、脑卒中合并率在三组间的差异无统计学意义(P>0.05)。②三组间高血压病程、高血压合并率、吸烟时间、吸烟率、HDL-C、FIB在三组之间的差异有统计学意义(P<0.05)。③Logistic回归分析结果显示TG、高血压、纤维蛋白原与老年LEAD的发生成正相关(P<0.05),HDL-C与LEAD成负相关(P<0.05)。④经过16个月随访,三组间生存率无显著差异(P>0.05)。结论:老年LEAD患者男性明显多于女性,且常有较高的吸烟率、高血压、糖尿病、脑卒中、血脂异常的合并率。TG、FIB水平增高及合并高血压病其下肢血管病变程度更重,是加剧下肢动脉硬化的主要因素,HDL-C对LEAD具有保护作用。经过16个月随访,老年LEAD患者死亡的主要原因为心脑血管疾病,与血管狭窄严重程度无相关性。 Objective:To investigate the prognosis and its related risk factors of 1ower extremity atherosclerotic disease in the elderly patients.Methods:To analyze retrospectively 181 cases with suffering from lower extremity atherosclerotic ischemia who were hospitalized in The First clinical college of Harbin Medical University from December 2004 to December 2009.All these patients were checked on both lowerlimbs by Doppler,the patients were classified into three groups:plaque formation(plaque),arterial stenosis(stenosis)(1uminal narrowing≥50)and arterial occlusion(occlusion).After collecting their clinical information such as gender,age,blood lipid profile FBG,fibrinogen(FIB),the history of hypertension,stroke and smoking and so on.The differences in ordinary and biochemical indices among these groups of patients were compared,and analyzed by the method of logistic regression.All of patients follow-up for 16 months,Observed in patients with primary endpoint events,including lower limb gangrene,side limb cycle,death.Results:There were no significant differences in age,the proportion of male and female,DM duration,TG,TC,LDL-C,FBG,dyslipidemia,coronary heart disease,stroke and the proportion of smoker among the three groups(P〉0.05).Among the three groups hypertension,hypertension with the rate of smoking time,smoking,HDL-C,FIB difference were statistically significant(P〈0.05).Logistic regression analysis showed that triglyceride(TG),hypertension,fibrinogen(FIB)were positive correlated with LEAD lesions(P〈0.05),while high-density lipoprotein cholesterol was negative correlated with LEAD lesions(P〈0.05).After16months of follow-up,among the three groups no significant difference in survival rates(P〉0.05).Conclusions:The number of male was obviously more than female's in patients with LEAD,and in whom there was a high prevalence of smoking,hypertension,DM,stroke and dyslipidemia.Triglyceride(TG),fibrinogen(FIB)levels increased in patients with hypertension and vascular lesions in the lower extremities increased the process severity advanced and were the major factors aggravating LEAD.HDL-C has a protective effect on LEAD.After 16months of follow-up,cardio cerebral disease is the main reason for death of patients which suffer from 1ower extremity atherosclerotic disease in the elderly patients and severity of vascular stenosis no correlation.
出处 《现代生物医学进展》 CAS 2010年第17期3254-3257,3247,共5页 Progress in Modern Biomedicine
关键词 LEAD 老年人 危险因素 预后 lower extremity atheroselerotic disease(LEAD), elderly, risk factor, prognosis
  • 相关文献

参考文献12

  • 1无.下肢动脉粥样硬化性疾病诊治中国专家建议(2007)[J].中华老年医学杂志,2007,26(10):725-740. 被引量:103
  • 2Coffrnan JD, Bernhard RT. Peripheral Arterial:Disease Diagnosis and Treatment [M].Totowa New Jersey: Humana Press, 2003,98-100.
  • 3Imamura M, Matsuo M, Miyahara T. Improvements in artery occlusion by low-density lipoprotein cholesterol in a patient with peripheral arterial disease[J] The cholesterol, 2002,6(6):467-470.
  • 4Touched H, Shigematsu H, Shimmer S. Effect of low-density lipoprotein cholesterol on patients with peripheral arterial disease. Peripheral Arterial Disease LDL cholesterol Multi center Study (PLAS) [J]. International Angiology,2006,25(3): 287-292.
  • 5Kosciusko ML. Lipoprotein (a) and at hero sclerosis: new perspectives on t he mechanism of action of an enigmatic lipoprotein [J]. Current At hero sclerosis Rep, 2005, 7 (5):389-395.
  • 6Huang ZF, Massey JB, Via DP. Differential regulation of cyclooxygenase-2(COX-2) mRNA stability by interleukin-1 beta (IL-lbeta) and tumor nerve factor-alpha (TNF-alpha) in human inVade differentiated macrophages Biochem-Phannacol[J].2000, 59 (2): 187-194.
  • 7Dovekie L, Macaw T, Schlesinger M. Fibrinogen predicts mortality in high risk patients with peripheral artery disease [J]. Euro J Vast End ovals Surge, 2003, 26 (4):381-386.
  • 8Willigendael EM, Tiepins JA, Bartlink ML. Influence of smoking on incidence and prevalence of peripheral arterial disease [J]. J Vas surge, 2004,40(6): 1158-1165.
  • 9Hey, Lam T H, Jinn B. Passive smoking and risk of peripheral arterial disease and ischemic stroke in Chinese women whoever smoked[J]. Circulation, 2008,118 : 1535-1540.
  • 10I Cliquey MH, Dannenberg JO, Anger RD. The epidemiology of peripheral arterial disease importance of identifying the population at risk[J]. Vas Med, 1997,2: 222-226.

二级参考文献37

  • 1李小鹰,王洁,何耀,范利.老年周围动脉硬化闭塞病与心血管疾病的关系——北京万寿路地区老年人群横断面调查[J].中华医学杂志,2003,83(21):1847-1851. 被引量:36
  • 2李小鹰,王洁,王全义,刘德新,范利.周围动脉硬化闭塞症在老年血脂异常人群中的现患率调查[J].中华老年心脑血管病杂志,2005,7(1):3-6. 被引量:74
  • 3刘成国,阮连生.浙江省舟山渔区外周动脉病患病率调查[J].中华老年医学杂志,2005,24(11):863-865. 被引量:12
  • 4魏毅东,胡大一,张润峰,郑黎强,李觉,余金明,邢燕.代谢综合征患者合并外周动脉疾病的临床研究[J].中华医学杂志,2006,86(30):2114-2116. 被引量:22
  • 5管珩,刘志民,李光伟,郭晓蕙,许樟榕,邹大进,邢惠莉,刘伟,盛正妍,田浩明,朱大龙,于德民,庄维特,陈璐璐,翁建平.50岁以上糖尿病人群周围动脉闭塞性疾病相关因素分析[J].中华医学杂志,2007,87(1):23-27. 被引量:120
  • 6Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/ AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease ( lower extremity, renal, mesenteric, and abdominal aortic):a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery,Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation, 2006, 113: 463-654.
  • 7Norgren I., Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC Ⅱ ). Eur J Vase Endovase Surg, 2007, 33(Suppl 1):S1-S75.
  • 8Gofin R, Kark JD, Friedlander Y, et al. Peripheral vascular disease in a middle-aged population sample. The Jerusalem Lipid Research Clinic Prevalence Study. Isr J Med Sci, 1987, 23:157-167,
  • 9Fowkes FG, Housley E, Cawood EH, et al. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol, 1991, 20:384-392.
  • 10Newman AB, Siscovick DS, Manolio TA, et al. Anklearm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study ( CHS ) Collaborative Research Group. Circulation, 1993,88 : 837-845.

共引文献102

同被引文献39

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部